ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Illinois » Internal Medicine

Top Internal Medicine Prescribers in Illinois

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
ILAXI PATEL D.O.

Internal Medicine

419

$7,841

283
215 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

8%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 25%

$19
Average prescription price

Avg: $60

PRASUN DAS MD

Internal Medicine

435

$8,910

321
276 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

9%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

10%
prescriptions for brand name drugs

Avg: 25%

$20
Average prescription price

Avg: $60

JAMAL ROSS M.D.

Internal Medicine

456

$24.5K

37
15 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 25%

$54
Average prescription price

Avg: $60

MAISARA KOBAISY M.D.

Internal Medicine

457

$22.5K

34
16 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 25%

$49
Average prescription price

Avg: $60

JACK PINTO MD

Internal Medicine

473

$39.2K

80
70 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$83
Average prescription price

Avg: $60

ALEX ULITSKY MD

Internal Medicine

482

$50.4K

137
85 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

40%
prescriptions for brand name drugs

Avg: 25%

$105
Average prescription price

Avg: $60

ANDREA SLASURAITIS MD

Internal Medicine

491

$21.2K

42
26 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 25%

$43
Average prescription price

Avg: $60

ROBERT DIETER MD

Internal Medicine

493

$42.1K

45
39 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

36%
prescriptions for brand name drugs

Avg: 25%

$85
Average prescription price

Avg: $60

FARIBA JAVADI M.D.

Internal Medicine

503

$108K

69
29 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 25%

$215
Average prescription price

Avg: $60

HILTON GORDON MD

Internal Medicine

510

$8,009

159
29 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

88%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

4%
prescriptions for brand name drugs

Avg: 25%

$16
Average prescription price

Avg: $60

BRYAN MCVAY D.O.

Internal Medicine

512

$192K

89
66 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

71%
prescriptions for brand name drugs

Avg: 25%

$375
Average prescription price

Avg: $60

THOMAS ALBERT D.C., M.D.

Internal Medicine

514

$25.9K

67
52 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$50
Average prescription price

Avg: $60

MICHEL GOWHARI D.O.

Internal Medicine

516

$61.7K

67
0 are 65+

52%
patients receiving schedule two controlled substances

Avg: 1%

40%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$120
Average prescription price

Avg: $60

LINDA CHAN M.D.

Internal Medicine

517

$105K

110
97 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

68%
prescriptions for brand name drugs

Avg: 25%

$203
Average prescription price

Avg: $60

ROBERT WOODRICK MD

Internal Medicine

522

$54.3K

153
122 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 25%

$104
Average prescription price

Avg: $60

DANIELA KOVACS MD

Internal Medicine

524

$23K

74
47 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

13%
prescriptions for brand name drugs

Avg: 25%

$44
Average prescription price

Avg: $60

CARL BARSANTI M.D.

Internal Medicine

525

$80.3K

106
101 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

66%
prescriptions for brand name drugs

Avg: 25%

$153
Average prescription price

Avg: $60

BERNARD WOLF D.O.

Internal Medicine

527

$71.4K

71
36 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 11%

12%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

10%
prescriptions for brand name drugs

Avg: 25%

$135
Average prescription price

Avg: $60

SREYA PALLATH MD

Internal Medicine

531

$113K

108
73 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

38%
prescriptions for brand name drugs

Avg: 25%

$213
Average prescription price

Avg: $60

NEETI SHARMA MD

Internal Medicine

533

$26.9K

42
25 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 25%

$50
Average prescription price

Avg: $60

CHOOL LIYANAPATABENDI MD

Internal Medicine

540

$24.7K

117
81 are 65+

15%
patients receiving schedule two controlled substances

Avg: 1%

21%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$46
Average prescription price

Avg: $60

MAY HASHIMI M.D.

Internal Medicine

541

$66.8K

78
69 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 25%

$124
Average prescription price

Avg: $60

THANDIWE GRAY M.D.

Internal Medicine

542

$246K

76
66 are 65+

16%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 25%

$454
Average prescription price

Avg: $60

MELANIE GORDON M.D.

Internal Medicine

543

$21.2K

57
35 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 25%

$39
Average prescription price

Avg: $60

CAROLINE POKU M.D.

Internal Medicine

546

$16.1K

51
35 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 25%

$30
Average prescription price

Avg: $60

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank